| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6175253 | European Urology | 2015 | 10 Pages |
Abstract
This review assesses evidence for the use of magnetic resonance imaging (MRI) in men on active surveillance for prostate cancer. MRI at the start of surveillance can detect clinically significant disease in one-third to half of men. There are few data to assess the use of MRI as a monitoring tool during surveillance, so there is a need to define significant disease on MRI and significant changes over time.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ivo G. Schoots, Neophytos Petrides, Francesco Giganti, Leonard P. Bokhorst, Antti Rannikko, Laurence Klotz, Arnauld Villers, Jonas Hugosson, Caroline M. Moore,